GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 767 filers reported holding GLAXOSMITHKLINE PLC in Q4 2016. The put-call ratio across all filers is 1.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $1,063,000 | +10.5% | 27,199 | +0.3% | 0.29% | +13.2% |
| Q4 2017 | $962,000 | -17.3% | 27,124 | -5.3% | 0.26% | -19.2% |
| Q3 2017 | $1,163,000 | +6.3% | 28,634 | +13.0% | 0.32% | +3.9% |
| Q2 2017 | $1,094,000 | +9.6% | 25,349 | +7.1% | 0.31% | +8.1% |
| Q1 2017 | $998,000 | +12.1% | 23,673 | +2.4% | 0.28% | +9.3% |
| Q4 2016 | $890,000 | -20.1% | 23,126 | -10.5% | 0.26% | -23.6% |
| Q3 2016 | $1,114,000 | -6.5% | 25,837 | -6.0% | 0.34% | -8.6% |
| Q2 2016 | $1,191,000 | +14.6% | 27,479 | +7.2% | 0.37% | +11.4% |
| Q1 2016 | $1,039,000 | +3.8% | 25,624 | +3.3% | 0.33% | +1.2% |
| Q4 2015 | $1,001,000 | +109.9% | 24,803 | +100.0% | 0.33% | -39.2% |
| Q3 2015 | $477,000 | -4.0% | 12,403 | +3.9% | 0.54% | +11.1% |
| Q2 2015 | $497,000 | +8.3% | 11,935 | +20.0% | 0.49% | +7.7% |
| Q1 2015 | $459,000 | +10.6% | 9,949 | +2.4% | 0.45% | +21.2% |
| Q4 2014 | $415,000 | – | 9,712 | – | 0.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chubb Ltd | 400,000 | $15,404,000 | 6.76% |
| KAHN BROTHERS GROUP INC | 833,315 | $32,090,960,000 | 5.42% |
| Sio Capital Management, LLC | 180,811 | $6,963,000 | 4.06% |
| Sio Capital Management, LLC | 170,000 | $6,547,000 | 3.82% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,124,462 | $43,304,000 | 3.12% |
| Keystone Financial Planning, Inc. | 120,705 | $4,648,000 | 3.04% |
| PVG Asset Management | 186,553 | $7,184,156,000 | 3.02% |
| P.R. Herzig & Co. Inc. | 37,950 | $1,461,000 | 2.98% |
| EQUITY INVESTMENT CORP | 2,329,469 | $89,708,000 | 2.89% |
| Sterneck Capital Management, LLC | 114,816 | $4,422,000 | 2.84% |